A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 68, Issue 9, Pages 2174-2183
Publisher
Wiley
Online
2016-04-26
DOI
10.1002/art.39722
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- THU0042 Preclinical Characterization of Sirukumab, a Human Monoclonal Antibody that Targets Human Interleukin-6 Signaling
- (2015) D. Gardner et al. ANNALS OF THE RHEUMATIC DISEASES
- Biologic Therapy in Lupus Nephritis
- (2015) Frédéric A. Houssiau NEPHRON CLINICAL PRACTICE
- Lupus Nephritis: From Pathogenesis to Targets for Biologic Treatment
- (2015) Yujuan Liu et al. NEPHRON CLINICAL PRACTICE
- Lupus Nephritis: The Evolving Role of Novel Therapeutics
- (2014) Brad H. Rovin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
- (2014) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients
- (2014) AS Alvarado et al. LUPUS
- Interleukin-6 in renal disease and therapy
- (2014) S. A. Jones et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus
- (2013) C. C. Mok et al. ARTHRITIS AND RHEUMATISM
- Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
- (2013) Jürgen Scheller et al. SEMINARS IN IMMUNOLOGY
- Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve-Month, Randomized, Double-Blind Study
- (2013) Richard Furie et al. Arthritis & Rheumatology
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis
- (2012) D-Y Chen et al. LUPUS
- Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months
- (2012) Z. Touma et al. RHEUMATOLOGY
- Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
- (2011) Zhenhua Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic and Pharmacodynamic Modeling of an Anti-Interleukin-6 Chimeric Monoclonal Antibody (Siltuximab) in Patients with Metastatic Renal Cell Carcinoma
- (2010) T. Puchalski et al. CLINICAL CANCER RESEARCH
- Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets
- (2010) Jasmine P. Davda et al. mAbs
- Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-Faslpr Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease in Systemic Lupus Erythematosus
- (2009) H. CASH et al. JOURNAL OF RHEUMATOLOGY
- A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis
- (2009) Derek M. Fine et al. KIDNEY INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started